392 related articles for article (PubMed ID: 28087360)
1. The synthetic peptide PnPP-19 induces peripheral antinociception via activation of NO/cGMP/K
Freitas AC; Silva GC; Pacheco DF; Pimenta AM; Lemos VS; Duarte ID; de Lima ME
Nitric Oxide; 2017 Apr; 64():31-38. PubMed ID: 28087360
[TBL] [Abstract][Full Text] [Related]
2. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to NO/cGMP and ATP-sensitive K(+) channels pathway activation in mice.
de Carvalho Veloso C; Rodrigues VG; Ferreira RC; Duarte LP; Klein A; Duarte ID; Romero TR; de Castro Perez A
Eur J Pharmacol; 2015 May; 755():1-5. PubMed ID: 25748602
[TBL] [Abstract][Full Text] [Related]
3. Ang-(1-7) activates the NO/cGMP and ATP-sensitive K+ channels pathway to induce peripheral antinociception in rats.
Costa A; Galdino G; Romero T; Silva G; Cortes S; Santos R; Duarte I
Nitric Oxide; 2014 Feb; 37():11-6. PubMed ID: 24361899
[TBL] [Abstract][Full Text] [Related]
4. Noradrenaline activates the NO/cGMP/ATP-sensitive K(+) channels pathway to induce peripheral antinociception in rats.
Romero TR; Guzzo LS; Perez AC; Klein A; Duarte ID
Nitric Oxide; 2012 Mar; 26(3):157-61. PubMed ID: 22330728
[TBL] [Abstract][Full Text] [Related]
5. Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Côrtes SF; Duarte ID
Anesth Analg; 2011 Nov; 113(5):1254-9. PubMed ID: 21788321
[TBL] [Abstract][Full Text] [Related]
6. Involvement of L-arginine/NO/cGMP/K(ATP) channel pathway in the peripheral antinociceptive actions of ellagic acid in the rat formalin test.
Ghorbanzadeh B; Mansouri MT; Hemmati AA; Naghizadeh B; Mard SA; Rezaie A
Pharmacol Biochem Behav; 2014 Nov; 126():116-21. PubMed ID: 25278343
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the L-arginine/Nitric Oxide/Cyclic GMP/KATP Channel Pathway and PPARγ Receptors in the Peripheral Antinociceptive Effect of Carbamazepine.
Ghorbanzadeh B; Kheirandish V; Mansouri MT
Drug Res (Stuttg); 2019 Dec; 69(12):650-657. PubMed ID: 31272117
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in peripheral antinociception induced by N-palmitoyl-ethanolamine in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Cortes SF; Duarte ID
J Neurosci Res; 2012 Jul; 90(7):1474-9. PubMed ID: 22411529
[TBL] [Abstract][Full Text] [Related]
9. The Nitric oxide/CGMP/KATP pathway mediates systemic and central antinociception induced by resistance exercise in rats.
Galdino GS; Xavier CH; Almeida R; Silva G; Fontes MA; Menezes G; Duarte ID; Perez AC
Int J Neurosci; 2015; 125(10):765-73. PubMed ID: 25271801
[TBL] [Abstract][Full Text] [Related]
10. The synthetic peptide PnPP-19 potentiates erectile function via nNOS and iNOS.
Silva CND; Pedrosa KN; Silva GCD; Cunha PDS; Diniz TF; Maia LMS; Almeida FM; Gomez RS; Lemos VS; Gomes DA; de Lima ME
Nitric Oxide; 2021 Sep; 113-114():23-30. PubMed ID: 33915274
[TBL] [Abstract][Full Text] [Related]
11. alpha(2)-Adrenoceptor agonist xylazine induces peripheral antinociceptive effect by activation of the L-arginine/nitric oxide/cyclic GMP pathway in rat.
Romero TR; Duarte ID
Eur J Pharmacol; 2009 Jun; 613(1-3):64-7. PubMed ID: 19389395
[TBL] [Abstract][Full Text] [Related]
12. Increased cavernosal relaxation by Phoneutria nigriventer toxin, PnTx2-6, via activation at NO/cGMP signaling.
Nunes KP; Wynne BM; Cordeiro MN; Borges MH; Richardson M; Leite R; DeLima ME; Webb RC
Int J Impot Res; 2012; 24(2):69-76. PubMed ID: 21975567
[TBL] [Abstract][Full Text] [Related]
13. Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine.
Amarante LH; Alves DP; Duarte ID
Eur J Pharmacol; 2004 Jun; 494(2-3):155-60. PubMed ID: 15212969
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol induces systemic analgesia through activation of the PI3Kγ/nNOS/NO/KATP signaling pathway in neuropathic mice. A KATP channel S-nitrosylation-dependent mechanism.
de Almeida DL; Mendes Ferreira RC; Fonseca FC; Dias Machado DP; Aguiar DD; Guimaraes FS; Duarte IDG; Romero TRL
Nitric Oxide; 2024 May; 146():1-9. PubMed ID: 38428514
[TBL] [Abstract][Full Text] [Related]
15. Participation of the NO/cGMP/K+ATP pathway in the antinociception induced by Walker tumor bearing in rats.
Barbosa AL; Pinheiro CA; Oliveira GJ; Torres JN; Moraes MO; Ribeiro RA; Vale ML; Souza MH
Braz J Med Biol Res; 2012 Jun; 45(6):531-6. PubMed ID: 22450376
[TBL] [Abstract][Full Text] [Related]
16. Alendronate induces gastric damage by reducing nitric oxide synthase expression and NO/cGMP/K(ATP) signaling pathway.
Silva RO; Lucetti LT; Wong DV; Aragão KS; Junior EM; Soares PM; Barbosa AL; Ribeiro RA; Souza MH; Medeiros JV
Nitric Oxide; 2014 Aug; 40():22-30. PubMed ID: 24831353
[TBL] [Abstract][Full Text] [Related]
17. The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids.
Negrete R; Hervera A; Leánez S; Martín-Campos JM; Pol O
PLoS One; 2011; 6(10):e26688. PubMed ID: 22031841
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive effect of Lonchocarpus araripensis lectin: activation of L-arginine/NO/cGMP/K
Assreuy AMS; Amorim RMF; Martins SL; de Queiroz Martins MG; Cajazeiras JB; da Silva MTL; Pires AF; Nascimento KS; Cavada BS; Mota MRL
Inflammopharmacology; 2020 Dec; 28(6):1623-1631. PubMed ID: 32572724
[TBL] [Abstract][Full Text] [Related]
19. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.
Pena-dos-Santos DR; Severino FP; Pereira SA; Rodrigues DB; Cunha FQ; Vieira SM; Napimoga MH; Clemente-Napimoga JT
Neuroscience; 2009 Nov; 163(4):1211-9. PubMed ID: 19647045
[TBL] [Abstract][Full Text] [Related]
20. PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase.
Freitas AC; Pacheco DF; Machado MF; Carmona AK; Duarte ID; de Lima ME
Br J Pharmacol; 2016 May; 173(9):1491-501. PubMed ID: 26947933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
